PolyPid licenses surgical infection prevention drug to Advanz

 Israeli drug advancement business PolyPid (Nasdaq: PYPD) currently announced that it has entered into an exclusive licensing agreement in Europe with Uk-primarily based specialty and hospital pharmaceutical firm Advanz…